by Riley Nolan | Nov 30, 2021 | Featured, Thinking Out Loud -Blog
Omicron, Oh My! Want to know if Omicron, the new COVID-19 variant, becoming ‘more stealth’? Watch our LinkedIn for an update on whether we expect to see the Variant of Concern escaping vaccine-induced immune response. I’ll be posting that on Tuesday Nov...
by Riley Nolan | Oct 28, 2021 | Featured, Thinking Out Loud -Blog
First Class? (Class I) Are you working with mRNA, CAR-T, or gene/cell therapy? Then this is news that you can use! EpiVax has First Class HLA Class I prediction tools. Assessing the immunogenicity risk of “new modalities” includes CTL (Class I) epitopes, addition to...
by Riley Nolan | Sep 29, 2021 | Featured, Thinking Out Loud -Blog
The Phat version of “The Skinny” Thinking Out Loud Blog This is truly Phat – we are taking action to keep your inbox thinner! In the latest Thinking Out Loud newsletter, I promised to share my COVID cooking obsession and some ideas about the balance between...
by Riley Nolan | Aug 31, 2021 | Featured, Thinking Out Loud -Blog
From Disco to BTS Time flies when you are having fun! I totally missed the 10th anniversary of “Thinking Out Loud” a.k.a TOL – this newsletter. Do you want to see the first post? I hope you like disco! Lucky for you, I’ve moved on...
by Riley Nolan | Aug 18, 2021 | Featured, Thinking Out Loud -Blog
EpiVax is excited to provide an update on our charitable giving activities from this spring and summer! The non-profits featured below are selected each quarter by our EpiVax employees, as part of our efforts to support the good work of community partners around...
by Riley Nolan | Jul 28, 2021 | Featured, Thinking Out Loud -Blog
(Delta) Variants at the Gates Been to the Disco lately? In the Netherlands, dancing is fueling a new wave of COVID infections. You can’t ignore the rise of COVID-19 cases globally after the Delta variant began circulating widely in June. Our hearts go out to...
